How to Repair Corrupt Exchange Databases Safely and Minimize Downtime
Veea Announces the VeeaONE Distributed Intelligence Platform, Enabling Cybersecure Sovereign Data Fabrics and Enterprise AI Grids for Physical AI
Teleskope Launches on the Slack App Marketplace, Reinforcing Position as Leading DSPM Platform with Native Remediation
Legal Decoder Launches Aperture, Bringing Conversational Analysis to Legal Billing Intelligence
Insignary Launches Clarity On-Demand: SBOMs, No Annual Commitment Required
Toronto, Ontario–(Newsfile Corp. – September 13, 2023) – Canadian-founded, rapidly growing automated pizzeria chain, PizzaForno, proudly…
Wizehire expands its products to help small growing businesses provide a best-in-class employee experience like…
Vancouver, BC, Sep 13, 2023 – (ACN Newswire) – Q2 Metals Corp. (TSXV: QTWO) (OTCQB:…
Integration streamlines development of generative AI applications via API with combination of serverless vector database…
The awards program celebrates the world’s most cutting-edge vendor and solution providers transforming the financial…
Continuous cyber risk assessments with actionable threat mitigation plans reduce breach likelihood and financial vulnerability…
New Solution Suite delivers Applied AI engineering to improve processes and profitability for oil and…
Station Implements Major Security Improvements After Radio Station’s Programming Disrupted with Scandinavian Rock MARIPOSA, Calif.,…
Strengthening customers’ ability to stay ahead of evolving cyber threats SAN ANTONIO , Sept. 13,…
Station Implements Major Security Improvements After Radio Station’s Programming Disrupted with Scandinavian Rock MARIPOSA, Calif.,…
PALO ALTO, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”…
PALO ALTO, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”…
Supply of drug substance manufactured under cGMP supports first-in-human clinical study for RBI-4000 novel self-replicating…
Supply of drug substance manufactured under cGMP supports first-in-human clinical study for RBI-4000 novel self-replicating…
NEW YORK and VIENNA, Sept. 13, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK,…
NEW YORK and VIENNA, Sept. 13, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK,…
Program will feature executive management plus key opinion leaders in immuno-oncology and vaccine development LAWRENCEVILLE,…
Program will feature executive management plus key opinion leaders in immuno-oncology and vaccine development LAWRENCEVILLE,…
The FDA’s response indicated that the planned toxicity study strategy is acceptable under FDA guidelines…
The FDA’s response indicated that the planned toxicity study strategy is acceptable under FDA guidelines…